A001
DYSREGULATED EXPRESSION OF HPV RELATED LNCRNA PTENP1 BY SMOKING INDUCES CANCER DRUG RESISTANCE AND RECURRENCE THROUGH C-MYC ACTIVATION
Cancer Biology
Zixing Liu; Jose Zevallos
Washington University in St Louis, School of Medcine
A002
IN VITRO AND IN VIVO EFFICACY OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
Yu-Jin Lee, MD1; Jacqueline Pei2; Estelle Martin1; Quan Zhou, PhD1; Marisa Hom, PhD3; Laura Freeman, MD1; Guolan Lu1; Eben Rosenthal, MD3
1Stanford University; 2University of Miami; 3Vanderbilt University
A004
CHARACTERIZATION OF HUMAN PAPILLOMAVIRUS IN SINONASAL SQUAMOUS CELL CARCINOMA
Elisabeth E Hansen, MSc1; Michael Lawrence, PhD2; Lisa Mirabello, PhD3; James S Lewis, MD4; Daniel L Faden, MD1
1Mass. Eye and Ear, Harvard Medical School; 2Mass. General Hospital, Harvard Medical School; 3NCI/NIH; 4Vanderbilt Medical Center
A005
THE TUMOR IMMUNE LANDSCAPE OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
Chareeni Kurukulasuriya, BS1; Honesty Kim, PhD2; Alex Trevino, PhD2; Blaize D'Anglo2; Ryan Preska2; Aaron Mayer, PhD2; Umamaheswar Duvvuri, MD, PhD3
1University of Pittsburgh School of Medicine; 2Enable Medicine; 3University of Pittsburgh Medical Center
A006
CISPLATIN RESISTANCE IN HEAD AND NECK CANCER: IMPACT OF SECONDHAND SMOKE EXPOSURE
Balaji Sadhasivam, PhD1; Jimmy Manyanga, PhD2; Vengatesh Ganapathy, PhD2; Célia Bouharati, BS2; Toral Mehta, PhD2; Basil Mathews, MD2; Samuel Castles, MD2; David Rubenstein, PhD3; Alayna Tackett, PhD4; Pawan Acharya, MS5; Daniel Zhao, PhD6; Lurdes Queimado, MD, PhD7
1Departments of Otolaryngology Head and Neck Surgery, The University of Oklahoma Health Sciences Center; 2Departments of Otolaryngology Head and Neck Surgery and Cell Biology, The University of Oklahoma Health Sciences Center; 3Department of Biomedical Engineering, Stony Brook University, New York; 4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles; 5Department of Biostatistics, The University of Oklahoma Health Sciences Center; 6Department of Biostatistics and TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center; 7Departments of Otolaryngology Head and Neck Surgery, Cell Biology, and TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center
AHNS01
RISK LEVEL STRATIFICATION USING CIRCULATING TUMOR DNA IN HEAD AND NECK CANCER PATIENTS
Liyona Kampel, MD, PhD; Sara Davidova, MD; Shlomo Zuriel, PhD; Narin Carmel Neiderman, MD; Dov Hershkovitz, MD, PhD; Nidal Muhanna, MD, PhD
Tel Aviv Sourasky Medical Center
AHNS02
EVEROLIMUS INHIBITS P53 MUTANT HNSCC BY MODULATING ANGIOGENESIS AND LYMPHANGIOGENESIS MECHANISMS LINKED TO MTOR/HIF1A/VEGF SIGNALING
Janmaris Marin Fermin; Md Maksudul Alam, PhD; Kyle A Boudreaux, MS, IV; Landon D Goodreau; Taylor L Powell; Tara Moore-Medlin; Xiaohua Rong; Jerry McLarty; Xin Gu; Cherie-Ann O Nathan
LSU-Health Shreveport
AHNS03
RADIATION IMPROVES THE THERAPEUTIC ANTIBODY DELIVERY IN HEAD AND NECK CANCERS.
Laura Freeman, MD; Guolan Lu, PhD; Eben Rosenthal
Stanford
AHNS04
CHARACTERIZING THE TUMOR MICROENVIRONMENT OF IMMUNOSUPPRESSED CUTANEOUS SQUAMOUS CELL CARCINOMA
Mica Glaun, MD1; Frederico Gleber-Netto, PhD1; Priyadharsini Nagarajan, MD1; Tongxin Xie1; Jennifer Covello1; Shamima Akhter1; Adebayo Adewale1; Erez Baruch1; Michael Wong1; Kenneth Tsai2; Elsa Flores2; Michael Migden1; Deborah Silverman1; Ryan Goepfert1; Yejing Ge1; Padamanee Sharma1; James Allison1; Jeffrey Myers1; Neil Gross1; Moran Amit1
1MD Anderson Cancer Center; 2Moffitt Cancer Center
AHNS06
MASS SPECTROMETRY IMAGING OF THE METABOLIC LANDSCAPE OF HUMAN PAPILLOMAVIRUS-ASSOCIATED VERSUS CARCINOGEN-DRIVEN HEAD AND NECK SQUAMOUS CELL CARCINOMA
Richard A Harbison, MD1; William Andrews2; Rajeev Pandey1; Rebecca Dempsey1; Rajarsi Mandal1; Robert Casero1; Drew Pardoll1; Carole Fakhry1; Maureen Kane2; Jonathan Powell1; Erika Pearce1
1Johns Hopkins Hospital; 2University of Maryland
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX